# Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer

> **NCT02344940** · PHASE4 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 104 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Toremifene
- **DRUG:** Tamoxifen

## Key facts

- **NCT ID:** NCT02344940
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2019-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02344940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02344940, "Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02344940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*